Results 221 to 230 of about 86,831 (312)

Colchicine for preventing stroke in patients with and without intracranial atherosclerotic stenosis: a prespecified analysis of a randomized clinical trial. [PDF]

open access: yesEClinicalMedicine
Li J   +37 more
europepmc   +1 more source

THE ANTIBACTERIAL ACTION OF COLCHICINE AND COLCHICEINE

open access: yesJournal of Pharmacy and Pharmacology, 1951
M. A. Gohar, M. Makkawi
openaire   +3 more sources

Abstracts

open access: yesMolecular Oncology, Volume 19, Issue S1, Page 1-895, June 2025.
Abstracts submitted to the ‘EACR 2025 Congress: Innovative Cancer Science’, from 16–19 June 2025 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Whole‐exome sequencing in families from Lifou Island (New Caledonia) reveals candidate variants involved in gout pathogenesis

open access: yesRheumatology &Autoimmunity, Volume 5, Issue 2, Page 147-151, June 2025.
Strategy to identify variants involved in gout pathogenesis in New Caledonia. Abstract Background Gout, which manifests as severe inflammation caused by excessive serum urate levels and monosodium urate deposits in the joints, is associated with multiple genomic loci in Europeans.
Philippe Georgel   +13 more
wiley   +1 more source

CLEAR results, cloudy impact: colchicine's neutral role in ST-segment elevation myocardial infarction. [PDF]

open access: yesEur Heart J Cardiovasc Pharmacother
Laudani C   +3 more
europepmc   +1 more source

Self-poisoning with colchicine [PDF]

open access: bronze, 1971
M. G. ELLWOOD, George Robb
openalex   +1 more source

Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study

open access: yesThe Journal of Dermatology, Volume 52, Issue 6, Page 983-1000, June 2025.
ABSTRACT Bullous pemphigoid (BP) is the most common autoimmune blistering skin disease worldwide. In the difficult‐to‐treat BP or if standard therapies are contraindicated, the use of biologics may be also considered although there is no strong evidence supporting their use.
Gianluca Avallone   +50 more
wiley   +1 more source

Increased Risk of Cardiovascular Events After Coronary Interventions in Inflammatory Bowel Disease: A Nationwide Matched Cohort Study

open access: yesAlimentary Pharmacology &Therapeutics, Volume 61, Issue 12, Page 1904-1912, June 2025.
Patients with inflammatory bowel diseases (IBD) were at 37% higher risk of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting. The elevated risk underscores the need for risk stratification before coronary interventions and intensified cardiovascular risk reduction in patients with IBD ...
Ramin Ebrahimi   +8 more
wiley   +1 more source

Patients with suspected pulmonary hypertension based on echocardiography in Behçet's disease: a 5-year follow-up study. [PDF]

open access: yesOrphanet J Rare Dis
Ekici M   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy